Are there ongoing trials exploring cannabis treatment for PMR?

Posted February 23, 2026 Updated February 23, 2026 Author: Julia Sutton, MSc Reviewed by: Dr. Clarissa Morton, PharmD

The use of cannabis in managing polymyalgia rheumatica is an evolving field, with researchers seeking to establish its effectiveness and safety. Ongoing cannabis trials for PMR aim to provide rigorous data on pain reduction, inflammation control, and overall patient wellbeing.

Current Research Landscape

Ongoing cannabis trials for PMR focus on various delivery methods, cannabinoid formulations, and dosing strategies. These trials are essential to determine how cannabis can be integrated into conventional PMR treatment plans.

Recruiting Studies

Several recruiting studies are actively seeking participants to evaluate the effects of cannabis on PMR symptoms. These studies often track outcomes like stiffness, mobility, and quality of life.

Clinical Research on Cannabis

Clinical research on cannabis is designed to generate evidence-based data that can guide healthcare professionals in prescribing and monitoring cannabis use for PMR. Safety and tolerability are key components of these investigations.

PMR Therapy Trials

PMR therapy trials explore how cannabis may complement existing therapies such as corticosteroids or NSAIDs. Researchers aim to identify optimal cannabinoid ratios and administration methods that maximise symptom relief while minimising side effects.

Ongoing cannabis trials for PMR are crucial in building a scientific foundation for therapeutic use. Through recruiting studies, clinical research on cannabis, and PMR therapy trials, patients and clinicians can access the latest evidence to make informed decisions, potentially improving symptom management and overall quality of life for those living with PMR.

If you’re exploring cannabis treatment options for polymyalgia rheumatica, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and polymyalgia rheumatica.

Written by

Julia Sutton, MSc

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Reviewed by

Dr. Clarissa Morton, PharmD

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.